Feast Ventures Hits First Close, Adds 5P's Health Team

TL;DR

Munich-based early-stage investor Feast Ventures has completed the first close of a new fund and, alongside it, announced a partnership with 5P – Future of Health, a Bochum-based healthtech investment boutique whose team is joining Feast to deepen its medical and clinical expertise. Neither party disclosed a fund size, deal terms, or how the combined team will be structured. The headline here isn't a dollar figure; it's a specialist food-and-agtech investor explicitly building out a combined food-and-health investment thesis by importing a dedicated healthtech investment team rather than hiring individual healthtech scouts.

Key Takeaways

Feast is pairing its first fund close with a real team-building move, and the team it's assembling may be the part of this announcement with the most staying power. Feast's own announcement bundles the first closing of its new fund with the arrival of 5P's investment team. 5P brings General Partners and venture partners with deep digital-health and clinical backgrounds, a different skill set than Feast's existing agriculture-and-food-focused bench. Bringing in an entire specialist team in one move is a faster, higher-conviction way to build credibility in a new vertical than hiring one or two healthtech-adjacent partners piecemeal.

Neither firm has shared a fund size yet, so we're reporting that plainly rather than filling in a number of our own. The VC Magazin announcement, a corroborating Startbase roundup, and Feast's own site all describe the close and the partnership without a single euro figure attached. We'll update this piece if and when Feast confirms one.

This combined food-and-health framing is a real attempt at thesis differentiation, not just marketing copy. Feast already organizes its investing around three verticals, agriculture inputs, next-gen food and ingredients, and prevention/nutrition/health, and bringing in a dedicated digital-health team extends that chain one step further into clinical and preventive care. Few European funds are explicitly underwriting the full chain from farm input to preventive health outcome in one vehicle.

5P's own identity is built around a specific medical framework, not a generic healthtech label. 5P organizes itself around five pillars, prevention, predictive medicine, participative health, precision medicine, and prolonged health, and several of its General Partners and venture partners, including Prof. Dr. Michael Friebe, Benjamin Niestroj, Till Grönemeyer and Simon Nopp, already appear on Feast Ventures' own team page as of this announcement, suggesting the team integration is already live rather than merely planned.

Fund Overview

Fund Name: Feast Ventures (the specific fund/vehicle name was not disclosed)
Fund Size: Not disclosed; only a first closing was announced, with no amount given
Stage: Early-stage / (Pre-)Seed, per Feast Ventures' own site
Check Size: Reported at €150,000–€500,000 per Feast Ventures' own site, typically for companies past proof-of-concept
Geography: Headquartered in Munich, Germany; invests primarily across Europe with strategic reach into APAC, plus 5P's additional network in Israel, Spain, Latin America and the US
Focus: A combined food, agriculture and health thesis spanning agricultural inputs (Grow Better), next-gen food and ingredients (Eat Better), and prevention, digital health and nutrition (Live Better)
Key LPs: Not disclosed

Why This Fund Matters

European micro-VCs increasingly compete on thesis depth rather than check size, because they can't out-fund a generalist growth fund and shouldn't try to. Feast Ventures, founded in 2022 as an early-stage micro-VC, has staked its position on the idea that food, agriculture and health are becoming a single investable stack rather than three separate categories. That's a defensible bet: the same macro pressures, input costs, climate stress on agriculture, rising chronic disease burden, consumer demand for preventive rather than reactive care, are pushing founders to build companies that sit across what used to be distinct sectors.

The harder part of that bet is credibility. A fund built around agricultural inputs and novel food ingredients doesn't automatically have the clinical, regulatory, or digital-health underwriting chops to evaluate a preventive-health or diagnostics startup well. That's precisely the gap 5P is built to fill: its General Partners come from clinical, research and university backgrounds, and the firm organizes its entire identity around a medical framework, the five 5P pillars, rather than a generic healthtech label. Folding that team into Feast, rather than Feast hiring a single healthtech-adjacent partner, is a more credible way to actually underwrite deals at the food-health intersection instead of just marketing a thesis about it.

There's a real network-effect argument here too. 5P's reach into Israel, Spain, Latin America and the US, combined with Feast's existing European and APAC relationships, gives the combined platform a wider deal-sourcing footprint than either firm had alone. Several 5P partners already appear on Feast's own site, which is a good early sign that the two teams are actually working together day to day, not just sharing a press release.

The obvious risk is dilution of focus. Micro-VCs succeed by being the most credible check for a narrow founder audience, and stretching from agri-inputs to digital-health diagnostics in one fund is a wide mandate for a firm writing €150K–€500K checks. Execution will depend on whether deal flow actually clusters at the intersection points (e.g., personalized nutrition, preventive diagnostics tied to dietary data) rather than the fund ending up as two loosely connected investing teams sharing a brand.

The Team

Benedikt Stoeckert is General Partner at Feast Ventures and spoke, in the announcement, to the data-driven case for food-and-health interventions. Prof. Dr. Michael Friebe is Founding Partner of 5P – Future of Health and addressed, in the same announcement, why companies that can prove both commercial scalability and measurable health outcomes will matter most. Feast's own site lists additional team members, including Dr. Alexander Wiegelmann, Sherry Yin, Simon Nopp, Dr. Phil Hackemann, Prof. Dr. Benjamin Niestroj, and Till Grönemeyer, without publicly specifying individual titles; several of these names (Niestroj, Grönemeyer, Nopp, Friebe, Hackemann) also appear in 5P's own team listing as General Partners, venture partners or fund managers, consistent with the stated team integration. We're not assigning specific GP titles to individuals beyond what each firm has stated directly, since neither firm has published a combined org chart.

Early Portfolio

Feast Ventures' own site lists a substantial existing portfolio predating this partnership, including HiveTracks, Readleaf Biologics, Protein Distillery, NEOH, Planet A Foods, Project Eaden, JNPR Spirits, Hey Holy, Evanium Healthcare, frank., Pumpkin Organics, Wholey Organics, Hello Inside, and Lifesum. No new investments from the first close of the new fund, or from the 5P partnership specifically, have been named yet.

What This Means for Founders

If you're building at the intersection of nutrition, agriculture, and health, particularly anything involving personalized nutrition, preventive diagnostics, or data-driven agricultural inputs with downstream health claims, this combined platform is now a more credible check than Feast alone would have been, because you get agri-food underwriting and clinical/digital-health underwriting in the same room. Expect the check to stay small (€150K–€500K) and early (post proof-of-concept), so this is a round-filler or co-lead for a seed round, not a Series A anchor.

Founders purely in digital health with no food, nutrition, or agriculture angle should be more cautious about assuming fit; Feast's thesis is explicitly about the intersection, not generic healthtech, so a pure diagnostics or care-delivery startup without a nutrition or food-systems angle may not be the fund's priority even with 5P's clinical bench now in-house.

Fund Momentum Take

The clearest evidence that this partnership is already working, rather than just announced, is that the team integration shows up on Feast's own site, not only in a press release. Firms that haven't actually brought a new team on board yet tend not to have already updated their team pages to reflect it, so this looks like the real thing.

The one gap worth watching is disclosure. Feast and 5P haven't shared a fund size yet, which makes it harder for founders and co-investors to calibrate how many checks this platform can write before it needs to raise again, though that's a normal feature of an early first close rather than a sign of trouble. We'd also note that Feast's own ticket-size and stage language varies slightly across sources, some describe pure (pre-)seed, others reference checks up to €1.5M, so founders should confirm directly with the firm.

Bottom line: a thesis-coherent partnership built around a genuinely underserved niche, the food-health intersection, with the two teams already working as one in practice. We'd just like to see the fund-size number land once the raise progresses.

Frequently Asked Questions

What did Feast Ventures and 5P – Future of Health announce?
Feast Ventures, a Munich-based early-stage investor in food, agriculture and health, announced the first closing of a new fund together with a partnership bringing 5P – Future of Health's healthtech investment team into Feast's platform.

How big is Feast Ventures' new fund?
Not disclosed. Neither firm's announcement nor independent coverage gives a fund size; only a first closing was confirmed, without a specific amount.

What does 5P – Future of Health focus on?
5P is a Bochum-based healthtech investment boutique organized around five pillars: prevention, predictive medicine, participative health, precision medicine, and prolonged health (longevity).

What stage and check size does the combined platform invest at?
Feast Ventures' own site lists €150,000–€500,000 checks, typically for early-stage companies past proof-of-concept.

Who leads each firm?
Benedikt Stoeckert is General Partner at Feast Ventures. Prof. Dr. Michael Friebe is Founding Partner at 5P – Future of Health. Other named team members at both firms include Benjamin Niestroj, Till Grönemeyer, Simon Nopp and Phil Hackemann, though specific combined-platform titles have not been published.

---

Have a fund closing to announce? Submit your fund here.

Need help raising capital? Check out our Fundraising Advisory services.